User profiles for Gerhard Krönke

Gerhard Krönke

Professor of Translational Immunology, University of Erlangen
Verified email at uk-erlangen.de
Cited by 8385

CD19-targeted CAR T cells in refractory systemic lupus erythematosus

D Mougiakakos, G Krönke, S Völkl… - … England Journal of …, 2021 - Mass Medical Soc
CAR T Cells for Refractory Systemic Lupus Erythematosus A 20-year-old woman with
refractory SLE with active lupus nephritis (WHO class IIIA), nephrotic syndrome, pericarditis, …

Locally renewing resident synovial macrophages provide a protective barrier for the joint

…, A Kleyer, F Paulsen, G Schett, A Hidalgo, G Krönke - Nature, 2019 - nature.com
Macrophages are considered to contribute to chronic inflammatory diseases such as rheumatoid
arthritis 1 . However, both the exact origin and the role of macrophages in inflammatory …

[HTML][HTML] Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss

…, O Schulz, B Krishnacoumar, G Krönke… - Nature …, 2018 - nature.com
Microbial metabolites are known to modulate immune responses of the host. The main
metabolites derived from microbial fermentation of dietary fibers in the intestine, short-chain fatty …

Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

…, C Scholtysek, C Dees, C Beyer, G Krönke… - Nature medicine, 2015 - nature.com
Mesenchymal responses are an essential aspect of tissue repair. Failure to terminate this
repair process correctly, however, results in fibrosis and organ dysfunction. Therapies that …

Autophagy regulates TNFα-mediated joint destruction in experimental arthritis

…, C Dees, A Distler, S Wirtz, G Krönke… - Annals of the …, 2013 - ard.bmj.com
Objectives Autophagy is a homeostatic process to recycle dispensable and damaged cell
organelles. Dysregulation of autophagic pathways has recently been implicated in the …

[HTML][HTML] Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

D Simon, K Tascilar, G Krönke, A Kleyer… - Nature …, 2020 - nature.com
Immune-mediated inflammatory diseases (IMIDs) of the joints, gut and skin are treated with
inhibitors of inflammatory cytokines. These cytokines are involved in the pathogenesis of …

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

…, C Buettner, KM Habenicht, TH Winkler, G Krönke… - Nature medicine, 2022 - nature.com
Systemic lupus erythematosus (SLE) is a life-threatening autoimmune disease characterized
by adaptive immune system activation, formation of double-stranded DNA autoantibodies …

[HTML][HTML] Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis

…, M Basic, A Kleyer, S Culemann, G Krönke… - Nature …, 2020 - nature.com
Gut microbial dysbiosis is associated with the development of autoimmune disease, but the
mechanisms by which microbial dysbiosis affects the transition from asymptomatic …

TNF-induced structural joint damage is mediated by IL-1

…, K Polzer, L Joosten, G Krönke… - Proceedings of the …, 2007 - National Acad Sciences
Blocking TNF effectively inhibits inflammation and structural damage in human rheumatoid
arthritis (RA). However, so far it is unclear whether the effect of TNF is a direct one or indirect …

Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease

…, S Blüml, F Nimmerjahn, G Schett, G Krönke - Nature …, 2017 - nature.com
The checkpoints and mechanisms that contribute to autoantibody-driven disease are as yet
incompletely understood. Here we identified the axis of interleukin 23 (IL-23) and the T H 17 …